David Lehr Research Award
The David Lehr Research Award honors outstanding research in clinical pharmacology and experimental therapeutics, recognizing impactful scientific contributions by senior investigators.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates: September 21, 2026
Funding Amounts: Prestigious recognition award; specific monetary value not stated, typically includes a commemorative honorarium.
Summary: Recognizes outstanding research accomplishments in clinical pharmacology and experimental therapeutics for investigators aged 45 or older.
Description
The David Lehr Research Award, presented by the American Society for Pharmacology and Experimental Therapeutics (ASPET), honors distinguished research accomplishments in the field of clinical pharmacology and experimental therapeutics. This award is designed to recognize investigators aged 45 or older whose work has significantly advanced the understanding and application of pharmacological principles in clinical settings. The award celebrates excellence and innovation in research that has a meaningful impact on clinical pharmacology and related experimental therapeutics.
